Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.

Abstract

In patients with tumor-associated myositis, it was more frequently necessary to administer other immunosuppressive drugs along with glucocorticoids. The successful treatment of the underlying malignant disease improved the clinical course of myositis. The overall survival rate was considerably worse when compared to other forms of myositis.